Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.52 USD | 0.00% |
|
+3.16% | -43.01% |
21/06 | Ironwood Pharmaceuticals Names Sravan Emany to Additional Role of Chief Operating Officer | MT |
20/06 | Ironwood Pharmaceuticals, Inc. Appoints Sravan K. Emany as Chief Operating Officer | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
Subscribe![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-43.01% | 103.64Cr | |
+16.59% | 4.55TCr | |
-9.89% | 3.85TCr | |
+38.08% | 3.81TCr | |
+27.12% | 3.07TCr | |
-8.64% | 2.6TCr | |
+11.81% | 2.59TCr | |
+45.08% | 1.41TCr | |
+32.85% | 1.27TCr | |
-7.19% | 1.13TCr |
- Stock Market
- Equities
- IRWD Stock
- News Ironwood Pharmaceuticals, Inc.
- Transcript : Ironwood Pharmaceuticals, Inc. Presents at JPMorgan 34th Annual Healthcare Conference, Jan-11-2016 01